CD56 bright natural killer cell induces HBsAg clearance via cytolysis and non-cytolysis: Analysis of the OSST patient dataset

被引:0
|
作者
Shi, A. [1 ]
Zhang, X. [1 ]
Xiao, F. [1 ]
Zhu, L. [1 ]
Yan, W. [1 ]
Han, M. [1 ]
Chen, T. [1 ]
Ning, Q. [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept & Inst Infect Dis, Wuhan, Hubei, Peoples R China
关键词
D O I
10.1016/S0168-8278(18)31274-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-334
引用
收藏
页码:S513 / S513
页数:1
相关论文
共 17 条
  • [1] CD56(+BRIGHT) BUT NOT CD56(+DIM) NATURAL-KILLER-CELL (NK), SUBSETS EXHIBIT CONTACT-MEDIATED PROLIFERATION
    PIERSON, BA
    MCGLAVE, PB
    HU, WS
    MILLER, JS
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 836 - 836
  • [2] Differential phenotypic properties of human peripheral blood CD56(dim+) and CD56(bright+) natural killer cell subpopulations
    Sedlmayr, P
    Schallhammer, L
    Hammer, A
    WildersTruschnig, M
    Wintersteiger, R
    Dohr, G
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 110 (04) : 308 - 313
  • [3] CD56bright natural killer cells induce HBsAg reduction via cytolysis and cccDNA decay in long-term entecavir-treated patients switching to peginterferon alfa-2a
    Shi, A.
    Zhang, X.
    Xiao, F.
    Zhu, L.
    Yan, W.
    Han, M.
    Luo, X.
    Chen, T.
    Ning, Q.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (11) : 1352 - 1362
  • [4] CD56(+bright) and CD56(+dim) natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis
    Pierson, BA
    Miller, JS
    BLOOD, 1996, 88 (06) : 2279 - 2287
  • [5] Leukaemia of natural killer cell large granular lymphocyte type with HLA-DR(-)CD16(-)CD56(bright+) phenotype
    Prieto, J
    Rios, E
    Parrado, A
    Martin, A
    deBlas, JM
    Rodriguez, JM
    JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (12) : 1011 - 1013
  • [6] Peg-interferon alpha induces CD56bright natural killer cell mediated reduction of HBsAg in entecavir treated chronic Hepatitis B patients
    Shi, Aichao
    Zhang, Xiaoping
    Xiao, Fang
    Yan, Weiming
    Han, Meifang
    Chen, Tao
    Ning, Qin
    HEPATOLOGY, 2017, 66 : 487A - 487A
  • [7] CD56(+bright) and CD56(+dim) natural killer cells in patients with chronic myelogenous leukemia (CML) demonstrate progressive decreases in number, cytotoxicity, clonogenic frequency, and proliferation on a per cell basis.
    Pierson, BA
    Miller, JS
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 577 - 577
  • [8] CD56(bright) natural killer cell subsets: Characterization of distinct functional responses to interleukin-2 and the c-kit ligand
    Carson, WE
    Fehniger, TA
    Caligiuri, MA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (02) : 354 - 360
  • [9] HAPLOIDENTICAL NATURAL KILLER CELL THERAPY: ANALYSIS OF 205 CLINIMACS PROCEDURES OF CD3 DEPLETION FOLLOWED BY CD56 SELECTION
    Tsang, K. S.
    Law, P.
    Sunkara, A.
    Triplett, B.
    Srinivasan, A.
    Leung, W.
    Kang, G.
    Eldridge, P.
    Janssen, W.
    CYTOTHERAPY, 2017, 19 (05) : S47 - S48
  • [10] Circulating CD56 bright natural killer cells after allogeneic stem cell trasnplantation express functional TRAIL; Implication for a novel target of immunotherapy
    Takao, S
    Ishikawa, T
    Ohmori, K
    Ishida, A
    Uchiyama, T
    BLOOD, 2005, 106 (11) : 437B - 437B